首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Human corneal stromal tissue concentration after consecutive doses of topically applied 3.3 vancomycin
【2h】

Human corneal stromal tissue concentration after consecutive doses of topically applied 3.3 vancomycin

机译:连续剂量局部应用​​3.3%万古霉素后人角膜基质组织浓度

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

>Aims: To evaluate vancomycin penetration into human corneal stromal tissue in patients treated with topical vancomycin eyedrops before penetrating keratoplasty (PKP).>Methods: Twenty four patients who underwent PKP, seven patients with keratoconus (group 1) and 17 patients with corneal scar or corneal decompensation (group 2). All patients received topical application of vancomycin eyedrops (concentration: 33 mg/ml) 10, 3, 2, 1 hour, and 15 minutes before the operation. Corneal cumulative vancomycin levels were assessed by bioassay.>Results: Mean vancomycin corneal stromal tissue concentration was 46.7 (SE 4.11) µg/g tissue. This value was four to 20-fold in excess of the MIC90 of vancomycin in Staphylococcus aureus (2–10 µg/ml).>Conclusions: Vancomycin reached high corneal tissue concentrations that significantly exceeded the MIC90 (2–10 µg/ml) for most key Gram positive corneal pathogens. The ratio of vancomycin stromal concentration to protein concentration was statistically higher in group 2 (non-keratoconus).
机译:>目的:在穿透性角膜移植术(PKP)之前,评估接受局部万古霉素滴眼液治疗的患者中万古霉素对人角膜基质组织的渗透。>方法: 24名接受PKP的患者,七名患者圆锥角膜(第1组)和17例角膜瘢痕或角膜代偿失调(第2组)的患者。所有患者在手术前10、3、2、1小时和15分钟接受局部应用万古霉素滴眼液(浓度:33 mg / ml)。通过生物测定法评估角膜累积万古霉素水平。>结果:万古霉素角膜基质组织平均浓度为46.7(SE 4.11)µg / g组织。该值是金黄色葡萄球菌中万古霉素的MIC90(2–10 µg / ml)的四到二十倍。>结论:万古霉素达到的高角膜组织浓度明显超过了MIC90(2– 10 µg / ml)用于大多数关键革兰氏阳性角膜病原体。在第二组(非圆锥角膜)中,万古霉素基质浓度与蛋白质浓度之比在统计学上较高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号